Brian Amos, Ph.D. Partner
| Direct | 212 336 8123 |
|---|---|
| Main | 212 336 8000 |
| Fax | 212 336 8001 |
E-mail
V-CardBrian J. Amos, Ph.D. is a former research neuroscientist who represents universities, research institutions and corporations in IP and data protection, including cultivating patent portfolios worldwide, predominantly in the fields of biotechnology, medical therapeutics & devices, AI applied to diagnostics & medical procedures, pharmaceuticals, and lithium ion battery technologies.
He works closely with scientists, in-house counsel and Technology Transfer Offices to identify and inventory new protectable IP and patentable technologies; protect discoveries through patents; and commercialize intellectual property through licensing and development arrangements with other business entities.
Dr. Amos’ specific areas of patent procurement include artificial intelligence-based technologies, diagnostic technologies, antibodies and fusion proteins, engineered immune therapeutics and targeted therapies, immune checkpoint interventions, recombinant live vaccines, vaccine enhancers, cancer therapies, nucleic acid sequencing technologies, siRNAs, antisense oligonucleotides, nucleic acid-based nanotechnologies, stem cell-based therapies, cardiac treatments, neurological therapies & rehabilitative interventions, EEG-based methods, medical devices, small molecules, pharmaceutical formulations, complete syntheses of natural products, biosensors, and lithium ion batteries & separators.
Dr. Amos has published articles in Nature Biotechnology and Oxford University Press on patent law issues and has been a webinar presenter to Tech Transfer professionals and other attorneys on subjects such as patentable subject matter in diagnostics, Bayh-Dole Act compliance, and university data policies & protection.
Because Dr. Amos works alongside patent litigators, his approach to patent prosecution is keenly formed by knowledge of how a patent may be challenged. In addition to having broad experience in all aspects of U.S. patent procurement, including ex-parte PTAB appeals, IPR, PGR, reissue, reexamination, and interference practice, he has extensive experience in international prosecution including before the European, Japanese, Chinese, Canadian and Australian patent offices, as well as European opposition practice. He coordinates U.S. and foreign prosecution with the goal of obtaining the most effective and strongest coverage available, with a particular focus on the most lucrative markets.
Dr. Amos received a Ph.D. in Neuroscience from the RFHSM, part of University College London which is consistently ranked among the world’s top universities, and graduated magna cum laude from New York Law School. He is admitted to the New York State Bar and is registered to practice before the U.S. Patent and Trademark Office.
Published Articles
-
Brian Amos and Charley Macedo Co-Author Article for Tech Transfer Central on SRA or RSA? They’re More Than Just Acronyms
-
Charley Macedo and Brian Amos Publish Article for Tech Transfer Tactics on Important Considerations in Crafting or Updating Institutional IP Policies
Tech Transfer Tactics, January 18, 2021
ARELaw Alerts
-
ARE Patent Law Alert: U.S. Patent and Trademark Office Announces New Fast-Track Appeals Pilot Program
-
ARE Patent Law Alert:
Federal Circuit Finds Method of Treatment Claims Patent-Eligible, Not Directed to Natural Law
In The Press
-
Event Spotlight: Brian Amos and Charley Macedo to Speak at LES Annual Meeting on Best Practices in Licensing Data and Software for AI/ML Applications
-
Amster Rothstein & Ebenstein Announces 2021 Lawyer Promotions
Bar Admissions
- New York, 2003
- U.S. Patent and Trademark Office
Education
- J.D., New York Law School, 2003 (Magna Cum Laude)
- Ph.D. in Neuroscience, Royal Free Hospital School of Medicine, University of London, 1994
- B.Sc. (Hons.) in Physiology, UCL, 1990
Professional Associations & Memberships
- New York Intellectual Property Lawyers Association
- American Intellectual Property Law Association
- American Chemical Society (ACS)
- Association of University Technology Managers (AUTM)
- Licensing Executives Society (LES)